Safety of tumor necrosis factor inhibitors use for rheumatoid arthritis and ankylosing spondylitis in Africa, the Middle East, and Asia: focus on severe infections and tuberculosis.
about
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab.Anti-TNF therapy in Jordan: a focus on severe infections and tuberculosis.An assessment of the current treatment landscape for rheumatology patients in Qatar: Recognising unmet needs and moving towards solutionsRheumatoid arthritis in the Middle East and Africa: are we any closer to optimising its management?Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice.
P2860
Safety of tumor necrosis factor inhibitors use for rheumatoid arthritis and ankylosing spondylitis in Africa, the Middle East, and Asia: focus on severe infections and tuberculosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Safety of tumor necrosis facto ...... e infections and tuberculosis.
@en
type
label
Safety of tumor necrosis facto ...... e infections and tuberculosis.
@en
prefLabel
Safety of tumor necrosis facto ...... e infections and tuberculosis.
@en
P2093
P2860
P1476
Safety of tumor necrosis facto ...... e infections and tuberculosis.
@en
P2093
Abdurhman Alarfaj
Der-Yuan Chen
Ehab Youseif
Hachemi Djoudi
Mohammed Hammoudeh
P2860
P304
P356
10.1007/S10067-012-2137-7
P577
2012-12-15T00:00:00Z